drugset / Trial / NCT02538848
Study of HTD4010 in Healthy Volunteers
RandomizedFactorialQuadruple-blindTreatment
Summary
To investigate safety and tolerability of HTD4010 after single ascending doses (SAD) in healthy volunteers
Timeline
- Start
- 2015-10
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HTD4010 | Peptide | 50 mg | — |
| Subject | HTD4010 | Peptide | 100 mg | — |
| Subject | HTD4010 | Peptide | 200 mg | — |
| Subject | HTD4010 | Peptide | 300 mg | — |